Monitoring of potassium and uric acid serum levels is recommended, especially in subjects with a predisposition to hypokalemia and in patients with gout. Although no allergic manifestations have been reported during clinical trials, patients with a history of allergy to sulfonamide derivatives should be closely monitored.
Caution must be observed during pregnancy and lactation.